Cargando…
Screening for inhibitor of episomal DNA identified dicumarol as a hepatitis B virus inhibitor
Currently, there is no available therapy to eradicate hepatitis B virus (HBV) in chronically infected individuals. This is due to the difficulty in eliminating viral covalently closed circular (ccc) DNA, which is central to the gene expression and replication of HBV. We developed an assay system for...
Autores principales: | Takeuchi, Fumihiko, Ikeda, Sotaro, Tsukamoto, Yuta, Iwasawa, Yoshikazu, Qihao, Chen, Otakaki, Yukie, Ryota, Ouda, Yao, Wan-Ling, Narita, Ryo, Makoto, Hijikata, Watashi, Koichi, Wakita, Takaji, Takeuchi, Koh, Chayama, Kazuaki, Kogure, Amane, Kato, Hiroki, Fujita, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380541/ https://www.ncbi.nlm.nih.gov/pubmed/30779774 http://dx.doi.org/10.1371/journal.pone.0212233 |
Ejemplares similares
-
Rosmarinic acid is a novel inhibitor for Hepatitis B virus replication targeting viral epsilon RNA-polymerase interaction
por: Tsukamoto, Yuta, et al.
Publicado: (2018) -
Coagulation, Thrombosis, and Dicumarol
por: Milstone, J. H.
Publicado: (1950) -
Establishment of a novel hepatitis B virus culture system using immortalized human hepatocytes
por: Akahori, Yuichi, et al.
Publicado: (2020) -
The Comparative Action of Dicumarol and of Phenylindanedione on the Coagulase Reacting Factor and on Prothrombin
por: Tager, Morris
Publicado: (1953) -
Topoisomerase Inhibitors Increase Episomal DNA Expression by Inducing the Integration of Episomal DNA in Hepatic Cells
por: Gómez-Moreno, Andoni, et al.
Publicado: (2023)